|
1
|
Kumar K, Tariq H, Ahmed R, Chukwunonso C,
Niazi M and Ihimoyan A: Small-cell type, poorly differentiated
neuroendocrine carcinoma of the gallbladder: A case report and
review of the literature. Case Rep Oncol Med.
2019:89680342019.PubMed/NCBI
|
|
2
|
Oberndorfer S: Carcinoid tumors of the
small intestine. Frank Z. Pathol. 1:426–429. 1907.(In German).
|
|
3
|
Gustafsson BI, Kidd M and Modlin IM:
Neuroendocrine tumors of the diffuse neuroendocrine system. Curr
Opin Oncol. 20:1–12. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yao JC, Hassan M, Phan A, Dagohoy C, Leary
C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A and Evans
DB: One hundred years after ‘carcinoid’: epidemiology of and
prognostic factors for neuroendocrine tumors in 35,825 cases in the
United States. J Clin Oncol. 26:3063–3072. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee KJ, Cho JH, Lee SH, Lee KH, Park BK,
Lee JK, Woo SM, Ryu JK, Lee JK, Kim YS, et al: Clinicopathological
characteristics of biliary neuroendocrine neoplasms: A multicenter
study. Scand J Gastroenterol. 52:437–441. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yun SP, Shin N and Seo HI: Clinical
outcomes of small cell neuroendocrine carcinoma and adenocarcinoma
of the gallbladder. World J Gastroenterol. 21:269–275. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lüttges J: What's new? The 2010 WHO
classification for tumours of the pancreas. Pathologe. 32 (Suppl
2):S332–S336. 2011.(In German). View Article : Google Scholar
|
|
8
|
Adachi T, Haraguchi M, Irie J, Yoshimoto
T, Uehara R, Ito S, Tokai H, Noda K, Tada N, Hirabaru M, et al:
Gallbladder small cell carcinoma: A case report and literature
review. Surg Case Rep. 2:712016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Duffy A, Capanu M, Abou-Alfa GK, Huitzil
D, Jarnagin W, Fong Y, D'Angelica M, Dematteo RP, Blumgart LH and
O'Reilly EM: Gallbladder cancer (GBC): 10-Year experience at
memorial sloan-kettering cancer centre (MSKCC). J Surg Oncol.
98:485–489. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Komori Y, Yada K, Ohta M, Uchida H,
Iwashita Y, Fukuzawa K, Kashima K, Yokoyama S, Inomata M and Kitano
S: Mammalian target of rapamycin signaling activation patterns in
pancreatic neuroendocrine tumors. J Hepatobiliary Pancreat Sci.
21:288–295. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Missiaglia E, Dalai I, Barbi S, Beghelli
S, Falconi M, della Peruta M, Piemonti L, Capurso G, Di Florio A,
delle Fave G, et al: Pancreatic endocrine tumors: Expression
profiling evidences a role for AKT-mTOR pathway. J Clin Oncol.
28:245–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takizawa N, Ohishi Y, Hirahashi M,
Takahashi S, Nakamura K, Tanaka M, Oki E, Takayanagi R and Oda Y:
Molecular characteristics of colorectal neuroendocrine carcinoma;
similarities with adenocarcinoma rather than neuroendocrine tumor.
Hum Pathol. 46:1890–1900. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujimasa K, Ohike N, Norose T, Isobe T,
Kikuchi K, Otsuka K, Murakami M and Takimoto M: Frequent and
specific involvement of changes of the p16-RB pathway in esophageal
neuroendocrine carcinoma. Anticancer Res. 39:1927–1934. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee SM and Sung CO: Neuroendocrine
carcinomas of the gallbladder: A clinicopathologic and
immunohistochemical analysis of 34 resected cases. Am J Surg
Pathol. 44:1308–1321. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park C, Ha SY, Kim ST, Kim HC, Heo JS,
Park YS, Lauwers G, Lee J and Kim KM: Identification of the BRAF
V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Oncotarget. 7:4024–4035. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Burkart J, Owen D, Shah MH, Abdel-Misih
SRZ, Roychowdhury S, Wesolowski R, Haraldsdottir S, Reeser JW,
Samorodnitsky E, Smith A and Konda B: Targeting BRAF mutations in
high-grade neuroendocrine carcinoma of the colon. J Natl Compr Canc
Netw. 16:1035–1040. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tashiro T, Imamura K, Tomita Y, Tamanoi D,
Takaki A, Sugahara K, Sato R, Saruwatari K, Sakata S, Inaba M, et
al: Heterogeneous tumor-immune microenvironments between primary
and metastatic tumors in a patient with ALK rearrangement-positive
large cell neuroendocrine carcinoma. Int J Mol Sci. 21:97052020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kumar A, Kumar B, Muthu GS and Mitra S:
68Ga-DOTANOC PET/CT detects a rare case of metastatic
neuroendocrine neoplasm of the gallbladder. Clin Nucl Med.
47:539–540. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Berzaczy D, Giraudo C, Haug AR, Raderer M,
Senn D, Karanikas G, Weber M and Mayerhoefer ME: Whole-body
68Ga-DOTANOC PET/MRI versus 68Ga-DOTANOC PET/CT in patients with
neuroendocrine tumors: A prospective study in 28 patients. Clin
Nucl Med. 42:669–674. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eltawil KM, Gustafsson BI, Kidd M and
Modlin IM: Neuroendocrine tumors of the gallbladder: An evaluation
and reassessment of management strategy. J Clin Gastroenterol.
44:687–695. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu J, Nikiforova MN, Hodak SP, Yim JH, Cai
G, Walls A, Nikiforov YE and Seethala RR: Tumor-to-tumor metastases
to follicular variant of papillary thyroid carcinoma: Histologic,
immunohistochemical, and molecular studies of two unusual cases.
Endocr Pathol. 20:235–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Machairas N, Paspala A, Frountzas M,
Tsilimigras DI, Moris D, Ntomi V, Tsapralis D and Schizas D: Mixed
adenoneuroendocrine carcinoma (MANEC) of the gallbladder: A
systematic review of outcomes following surgical management. In
Vivo. 33:1721–1726. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kalekou H and Miliaras D: Cytokeratin 7
and 20 expression in gallbladder carcinoma. Pol J Pathol. 62:25–30.
2011.PubMed/NCBI
|
|
24
|
La Rosa S, Marando A, Furlan D, Sahnane N
and Capella C: Colorectal poorly differentiated neuroendocrine
carcinomas and mixed adenoneuroendocrine carcinomas: Insights into
the diagnostic immunophenotype, assessment of methylation profile,
and search for prognostic markers. Am J Surg Pathol. 36:601–611.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krug LM, Crapanzano JP, Azzoli CG, Miller
VA, Rizvi N, Gomez J, Kris MG, Pizzo B, Tyson L, Dunne M and Heelan
RT: Imatinib mesylate lacks activity in small cell lung carcinoma
expressing c-kit protein: A phase II clinical trial. Cancer.
103:2128–2131. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ayabe RI, Wach M, Ruff S, Martin S, Diggs
L, Wiemken T, Hinyard L, Davis JL, Luu C and Hernandez JM: Primary
gallbladder neuroendocrine tumors: Insights into a rare histology
using a large national database. Ann Surg Oncol. 26:3577–3585.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu W, Chen W, Chen J, Hong T, Li B, Qu Q
and He X: Neuroendocrine carcinoma of gallbladder: A case series
and literature review. Eur J Med Res. 24:82019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Iype S, Mirza TA, Propper DJ, Bhattacharya
S, Feakins RM and Kocher HM: Neuroendocrine tumours of the
gallbladder: Three cases and a review of the literature. Postgrad
Med J. 85:213–218. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Niu C, Wang S, Guan Q, Ren X, Ji B and Liu
Y: Neuroendocrine tumors of the gallbladder. Oncol Lett.
19:3381–3388. 2020.PubMed/NCBI
|
|
30
|
Chiorean L, Bartos A, Pelau D, Iancu D,
Ciuleanu T, Buiga R, Oancea I, Mangrau A, Iancu C and Badea R:
Neuroendocrine tumor of gallbladder with liver and retroperitoneal
metastases and a good response to the chemotherapeutical treatment.
J Med Ultrason (2001). 42:271–276. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Elahi F, Ahmadzadeh A, Yadollahzadeh M,
Hassanpour K and Babaei M: Neuroendocrine tumor of the gallbladder.
Arch Iran Med. 16:123–125. 2013.PubMed/NCBI
|
|
32
|
Okuyama Y, Fukui A, Enoki Y, Morishita H,
Yoshida N and Fujimoto S: A large cell neuroendocrine carcinoma of
the gall bladder: Diagnosis with 18FDG-PET/CT-guided biliary
cytology and treatment with combined chemotherapy achieved a
long-term stable condition. Jpn J Clin Oncol. 43:571–574. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Raymond E, Dahan L, Raoul JL, Bang YJ,
Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A,
et al: Sunitinib malate for the treatment of pancreatic
neuroendocrine tumors. N Engl J Med. 364:501–513. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yao JC, Shah MH, Ito T, Bohas CL, Wolin
EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG,
et al: Everolimus for advanced pancreatic neuroendocrine tumors. N
Engl J Med. 364:514–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yan S, Wang Y, Chen X, Zhang Y, Huang Z,
Zhao J, Zhou J, Li Z, Bi X, Luo Z, et al: Clinical analysis of 15
cases of gallbladder neuroendocrine carcinoma and comparison with
gallbladder adenocarcinoma using a propensity score matching.
Cancer Manag Res. 12:1437–1446. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu W, Chen W, He X, Qu Q, Hong T and Li
B: Cholecystectomy with gallbladder bed cautery might be sufficient
for T1bN0M0 neuroendocrine carcinoma of gallbladders: Cases report
and literature review. Medicine (Baltimore). 96:e87782017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kanetkar AV, Patkar S, Khobragade KH,
Ostwal V, Ramaswamy A and Goel M: Neuroendocrine carcinoma of
gallbladder: A step beyond palliative therapy, experience of 25
cases. J Gastrointest Cancer. 50:298–303. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen C, Wang L, Liu X, Zhang G, Zhao Y and
Geng Z: Gallbladder neuroendocrine carcinoma: Report of 10 cases
and comparision of clinicopathologic features with gallbladder
adenocarcinoma. Int J Clin Exp Pathol. 8:8218–8226. 2015.PubMed/NCBI
|
|
39
|
de Mestier L, Cros J, Neuzillet C, Hentic
O, Egal A, Muller N, Bouché O, Cadiot G, Ruszniewski P, Couvelard A
and Hammel P: Digestive system mixed
neuroendocrine-non-neuroendocrine neoplasms. Neuroendocrinology.
105:412–425. 2017. View Article : Google Scholar : PubMed/NCBI
|
